Journal of Cancer Therapy

Volume 11, Issue 3 (March 2020)

ISSN Print: 2151-1934   ISSN Online: 2151-1942

Google-based Impact Factor: 0.30  Citations  h5-index & Ranking

Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

HTML  XML Download Download as PDF (Size: 333KB)  PP. 115-123  
DOI: 10.4236/jct.2020.113010    718 Downloads   1,597 Views  Citations
Author(s)

ABSTRACT

The prognosis of hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is very poor although sorafenib is recommended as the first-line treatment. Therefore, an effective treatment regime is needed for treating HCC with PVTT. This review summarized seven potential treatment regimes which including transarterial chemoembolization (TACE), TACE combined with sorafenib, TACE combined with radiotherapy (RT), hepatectomy, hepatic arterial infusion chemotherapy (HAIC), HAIC combined with sorafenib and HAIC combined with RT in the treatment of HCC with PVTT. In conclusion, hepatectomy or the combination of HAIC and sorafenib may be a more effective modality in the treatment of HCC patients with type I - II PVTT. HAIC combined with or without sorafenib/RT or the combination of RT and TACE is an alternative treatment choice for HCC patients with type III - IV PVTT. Further randomized controlled studies are warranted.

Share and Cite:

Shi, J. , Shen, A. , Mou, T. and Wu, Z. (2020) Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Journal of Cancer Therapy, 11, 115-123. doi: 10.4236/jct.2020.113010.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.